tirzepatide adolescent A Study of in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) Kids approved for weight loss

Research shows that some patients achieve meaningful weight reduction on lower doses, though individual response varies significantly based on genetics and metabolic factors

CJC-1295 without DAC (sometimes called modified GRF 1-29) has a shorter half-life of about 30 minutes and produces a more pulsatile GH release pattern, dosed daily

Mounjaro is an injectable weekly medication for obesity and type 2 diabetes, approved by the Central Drugs Standard Control Organization (CDSCO) in India

This article provides evidence-based information to help patients and healthcare professionals navigate this complex topic, emphasising the importance of open communication with prescribers about all substance use

Morrot A, da Fonseca LM, Salustiano EJ, Gentile LB, Conde L, Filardy AA, et al

For many adults, these medications really are helping